| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income | 165 | 209 | ||
| Net loss before benefit from income taxes and noncontrolling interests | -4,249 | -4,659 | ||
| Benefit from income taxes | 0 | 0 | ||
| Net loss | -4,249 | -4,659 | ||
| Less - net income (loss) attributable to noncontrolling interests | 0 | 0 | ||
| Net loss attributable to lisata therapeutics, inc. common stockholders | -4,249 | -4,659 | ||
| Basic shares (in shares) | 8,738,000 | 8,605,000 | ||
| Diluted shares (in shares) | 8,738,000 | 8,605,000 | ||
| Lisata therapeutics, inc. common stockholders - diluted (in usd per share) | -0.49 | -0.54 | ||
| Lisata therapeutics, inc. common stockholders- basic (in usd per share) | -0.49 | -0.54 | ||
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)